Literature DB >> 7586525

Serum bilirubin and risk of ischemic heart disease in middle-aged British men.

L H Breimer1, G Wannamethee, S Ebrahim, A G Shaper.   

Abstract

The possibility that low concentrations of serum bilirubin may be associated with increased risk of ischemic heart disease has been examined in a prospective study of 7685 middle-aged British men. During 11.5 years there were 737 major ischemic heart disease (IHD) events. A U-shaped relationship was observed between serum bilirubin and risk of IHD. Low bilirubin was associated with several cardiovascular risk factors, in particular smoking, low concentrations of high-density lipoprotein cholesterol, low forced expiratory volume in 1 s, and low serum albumin. The U-shaped relationship persisted even after adjusting for several risk factors. Compared with men in the lowest fifth of the distribution (bilirubin < 7 mumol/L), those in the middle range (8-9 mumol/L) showed a 30% reduction in relative risk [RR = 0.68 (95% confidence intervals 0.51-0.89)] in IHD, whereas men in the top fifth (> 12 mumol/L) showed similar risk to the lowest fifth [RR = 0.99 (95% confidence intervals 0.73-1.34)], which persisted after exclusion of men with bilirubin > 17 mumol/L. The significance of this U-shaped relationship is unclear, but it could be interpreted as support for the role of endogenous antioxidants in the etiology of IHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586525

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  55 in total

1.  Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study.

Authors:  Jing-Ping Lin; L Adrienne Cupples; Peter W F Wilson; Nancy Heard-Costa; Christopher J O'Donnell
Journal:  Am J Hum Genet       Date:  2003-02-28       Impact factor: 11.025

2.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

3.  Bilirubin Links Heme Metabolism to Neuroprotection by Scavenging Superoxide.

Authors:  Chirag Vasavda; Ruchita Kothari; Adarsha P Malla; Robert Tokhunts; Anthony Lin; Ming Ji; Cristina Ricco; Risheng Xu; Harry G Saavedra; Juan I Sbodio; Adele M Snowman; Lauren Albacarys; Lynda Hester; Thomas W Sedlak; Bindu D Paul; Solomon H Snyder
Journal:  Cell Chem Biol       Date:  2019-07-25       Impact factor: 8.116

4.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

5.  Biliverdin protects against the deterioration of glucose tolerance in db/db mice.

Authors:  N Ikeda; T Inoguchi; N Sonoda; M Fujii; R Takei; E Hirata; H Yokomizo; J Zheng; Y Maeda; K Kobayashi; R Takayanagi
Journal:  Diabetologia       Date:  2011-05-26       Impact factor: 10.122

6.  Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention.

Authors:  Chun-Chin Chang; Chien-Yi Hsu; Po-Hsun Huang; Chia-Hung Chiang; Shao-Sung Huang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

7.  Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention.

Authors:  Hai-Mu Yao; De-Liang Shen; Xiao-Yan Zhao; Xiao-Fang Wang; Tong-Wen Sun; Jin-Ying Zhang; Ling Li; Luo-Sha Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

9.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

10.  The role of bilirubin and its protective function against coronary heart disease.

Authors:  A Erkan; B Ekici; M Uğurlu; G Iş; R Seker; S Demirtaş; S Korkmaz
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.